Inhibiting tumour metastasis by DQA modified paclitaxel plus ligustrazine micelles in treatment of non-small-cell lung cancer

References

• Torre LA, Siegel RL, Jemal A. Lung cancer statistics. Adv Exp Med Biol. 2016;893:1–19.
   PubMed Web of Science ®Google Scholar
• Dubey P, Gidwani B, Pandey R. In vitro and in vivo evaluation of PEGylated nanoparticles of bendamustine for treatment of lung cancer. Artif Cells Nanomed Biotechnol. 2016;44:1491–1497.
   PubMed Web of Science ®Google Scholar
• Dearing KR, Sangal A, Weiss GJ. Maintaining clarity: review of maintenance therapy in non-small cell lung cancer. WJCO. 2014;5:103–113.
   Google Scholar
• Graham EA, Singer JJ. Successful removal of an entire lung for carcinoma of the bronchus. CA Cancer J Clin. 1974;24:238–242.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Zhu R, Wang M, et al. Anti-metastatic and anti-angiogenic activities of core-shell SiO2@LDH loaded with etoposide in non-Small cell lung cancer. Adv Sci (Weinh). 2016;3:1600229.
   PubMedGoogle Scholar
• Zhang L, Liu Z, Yang K, et al. Tumor progression of non-small cell lung cancer controlled by albumin and micellar nanoparticles of itraconazole, a multitarget angiogenesis inhibitor. Mol Pharmaceutics.. 2017;14:4705–4713.
   PubMed Web of Science ®Google Scholar
• Chen X, Sun X, Guan J, et al. Rsf-1 influences the sensitivity of non-small cell lung cancer to paclitaxel by regulating NF-κB pathway and its downstream proteins. Cell Physiol Biochem. 2017;44:2322–2336.
   PubMed Web of Science ®Google Scholar
• Jain MM, Gupte SU, Patil SG, et al. Paclitaxel injection concentrate for nanodispersion versus nab-paclitaxel in women with metastatic breast cancer: a multicenter, randomized, comparative phase II/III study. Breast Cancer Res Treat. 2016;156:125–134.
   PubMed Web of Science ®Google Scholar
• Wang HY, Zhang XR. Comparison of efficacy and safety between liposome-paclitaxel injection plus carboplatin and paclitaxel plus carboplatin as first line treatment in advanced non-small cell lung cancer. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2014;36:305–308.
   PubMedGoogle Scholar
• Wang X, Cheng L, Xie HJ, et al. Functional paclitaxel plus honokiol micelles destroying tumour metastasis in treatment of non-small-cell lung cancer. Artif Cells Nanomed Biotechnol. 2018;46:1154–1169.
   PubMed Web of Science ®Google Scholar
• Parent LR, Bakalis E, Ramírez-Hernández A, et al. Directly observing micelle fusion and growth in solution by liquid-cell transmission electron microscopy. J Am Chem Soc. 2017;139:17140–17151.
   PubMed Web of Science ®Google Scholar
• Zhao J, Xu Y, Wang C, et al. Soluplus/TPGS mixed micelles for dioscin delivery in cancer therapy. Drug Dev Ind Pharm. 2017;43:1197–1204.
   PubMed Web of Science ®Google Scholar
• Yu H, Xia D, Zhu Q, et al. Supersaturated polymeric micelles for oral cyclosporine A delivery. Eur J Pharm Biopharm. 2013;85:1325–1336.
   PubMed Web of Science ®Google Scholar
• Jin X, Zhou B, Xue L, et al. Soluplus(®) micelles as a potential drug delivery system for reversal of resistant tumor. Biomed Pharmacother. 2015;69:388–395.
   PubMed Web of Science ®Google Scholar
• Zou Y, Zhao D, Yan C, et al. Novel ligustrazine-based analogs of piperlongumine potently suppress proliferation and metastasis of colorectal cancer cells in vitro and in vivo. J Med Chem. 2018;61:1821–1832.
   PubMed Web of Science ®Google Scholar
• Shen J, Zeng L, Pan L, et al. Tetramethylpyrazine regulates breast cancer cell viability, migration, invasion and apoptosis by affecting the activity of Akt and caspase-3. Oncol Lett. 2018;15:4557–4563.
   PubMed Web of Science ®Google Scholar
• Zheng CY, Xiao W, Zhu MX, et al. Inhibition of cyclooxygenase-2 by tetramethylpyrazine and its effects on A549 cell invasion and invasion and metastasis. Int J Oncol. 2012;40:2029–2037.
   PubMed Web of Science ®Google Scholar
• Yu K, Chen Z, Pan X, et al. Tetramethylpyrazine-mediated suppression of C6 gliomas involves inhibition of chemokine receptor CXCR4 expression. Oncol Rep. 2012;28:955–960.
   PubMed Web of Science ®Google Scholar
• Szymusiak M, Kalkowski J, Luo H, et al. Core-shell structure and aggregation number of micelles composed of amphiphilic block copolymers and amphiphilic heterografted polymer brushes determined by small-angle x-ray scattering. ACS Macro Lett. 2017;6:1005–1012.
   PubMed Web of Science ®Google Scholar
• Li XT, Zhou ZY, Jiang Y, et al. PEGylated VRB plus quinacrine cationic liposomes for treating non-small cell lung cancer. J Drug Target. 2015;23:232–243.
   PubMed Web of Science ®Google Scholar
• Zhang C, Yu G, Shen Y. The naturally occurring xanthone α-mangostin induces ROS-mediated cytotoxicity in non-small scale lung cancer cells. Saudi J Biol Sci. 2018;25:1090–1095.
   PubMed Web of Science ®Google Scholar
• Yang D, Dai R, Zhang Q, et al. Apatinib for heavily treated patients with non-small cell lung cancer: report of a case series and literature review. Saudi J Biol Sci. 2018;25:888–894.
   PubMed Web of Science ®Google Scholar
• Abraham C, Garsa A, Badiyan SN, et al. Internal dose escalation is associated with increased local control for non-small cell lung cancer (NSCLC) brain metastases treated with stereotactic radiosurgery (SRS). Adv Radiat Oncol. 2018;3:146–153.
   PubMedGoogle Scholar
• Liu G, Li K, Wang H. Polymeric micelles based on PEGylated chitosan-g-lipoic acid as carrier for efficient intracellular drug delivery. J Biomater Appl. 2017;31:1039–1048.
   PubMed Web of Science ®Google Scholar
• Liu Z-L, Wang C, Chen H-J, et al. Bone metastasis from lung cancer identified by genetic profiling. Oncol Lett. 2017;13:847–850.
   PubMed Web of Science ®Google Scholar
• Sun YW, Xu J, Zhou J, et al. Targeted drugs for systemic therapy of lung cancer with brain metastases. Oncotarget. 2018;9:5459–5472.
   PubMedGoogle Scholar
• Thakur C, Rapp UR, Rudel T. Cysts mark the early stage of metastatic tumor development in non-small cell lung cancer. Oncotarget. 2017;9:6518–6535.
   PubMedGoogle Scholar
• Glinsky GV. Activation of endogenous human stem cell-associated retroviruses (SCARs) and therapy-resistant phenotypes of malignant tumors. Cancer Lett. 2016;376:347–359.
   PubMed Web of Science ®Google Scholar
• Schnegg CI, Yang MH, Ghosh SK, et al. Induction of vasculogenic mimicry overrides VEGF-A silencing and enriches stem-like cancer cells in melanoma. Cancer Res. 2015;75:1682–1690.
   PubMed Web of Science ®Google Scholar
• Ju RJ, Cheng L, Qiu X, et al. Hyaluronic acid modified daunorubicin plus honokiol cationic liposomes for the treatment of breast cancer along with the elimination vasculogenic mimicry channels. J Drug Target. 2018;26:793–805.
   PubMed Web of Science ®Google Scholar
• Fu N, Li H, Sun J, et al. Aqueous extract enhances the mobilization of endothelial progenitor cells and up-regulates the expression of VEGF, eNOS, NO, and MMP-9 in acute myocardial ischemic rats. Front Physiol. 2018;17:1132.
   Web of Science ®Google Scholar
• Rivera-Pérez J, Monter-Vera MDR, Barrientos-Alvarado C, et al. Evaluation of VEGF and PEDF in prostate cancer: a preliminary study in serum and biopsies. Oncol Lett. 2018;15:1072–1078.
   PubMed Web of Science ®Google Scholar
• Lu S, Zhang Z, Chen M, et al. Silibinin inhibits the migration and invasion of human gastric cancer SGC7901 cells by downregulating MMP-2 and MMP-9 expression via the p38MAPK signaling pathway. Oncol Lett. 2017;14:7577–7582.
   PubMed Web of Science ®Google Scholar
• Tao MZ, Gao X, Zhou TJ, et al. Effects of TGF-β1 on the proliferation and apoptosis of human cervical cancer hela cells in vitro. Cell Biochem Biophys. 2015;73:737–741.
   PubMed Web of Science ®Google Scholar
• Gao J, Zhu Y, Nilsson M, et al. TGF-β isoforms induce EMT independent migration of ovarian cancer cells. Cancer Cell Int. 2014;14:72.
   PubMed Web of Science ®Google Scholar
• Rötzer V, Hartlieb E, Vielmuth F, et al. E-cadherin and Src associate with extradesmosomal Dsg3 and modulate desmosome assembly and adhesion. Cell Mol Life Sci. 2015;72:4885–4897.
   PubMed Web of Science ®Google Scholar